Search Results

Your search matched 28 results

#1

Health Equity, Real-World Evidence: A Trend to Watch | Blog

The Biden administration cited health equity as one of its top 5 health priorities in a Health Affairs blog.

#2

Why the New CMS Oncology Model is an Inflection Point in Advancing Health Equity | Blog

On July 1st, The Centers for Medicare & Medicaid Services, through its Center for Medicare & Medicaid Innovation (CMMI), announced its newest voluntary oncology payment model, Enhancing Oncology Model (EOM).

#3

TRUMP OR CLINTON? | In The Media

The Mental Health Parity and Addiction Equity Act of 2008 forged a legal framework to guarantee people with mental health conditions the same access to care and coverage as those with physical conditions or injuries.

#4

How Pharma Can Fight Social Determinants of Health | Blog

In 2020 Health Trends, we called one of the major emerging developments in healthcare “Acting on Equity,” and it was about all the ways in which healthcare’s stark inequalities were getting new attention from leaders in life sciences.

#5

Solving the Founder/Funder Conundrum to Drive Health Equity and Support Marginalized Communities – a Q&A | Blog

At the 2022 BIO International Convention in San Diego, a panel explored how gaps in VC funding of Black- and women-led start-ups impact the development of scientific breakthroughs, new inventions, and business creation.

#6

Addressing Health Disparities Will Take a Village | Blog

While pharmaceutical manufacturers need to continue engaging with the broader healthcare system to help address healthcare disparities in the long term, there is action they can take now.

#7

Leading Through Awakening, Accountability and Equity | In The Media

Executives in healthcare recognized the necessity of taking a position on diversity and inclusion during the recent protests for racial equity.

#8

The Case for a Strong Corporate or Master Brand: the Next Step in the Evolution of the Pharma Industry | Blog

The Case for a Strong Corporate or Master Brand: the Next Step in the Evolution of the Pharma Industry

#9

How To Promote Diversity and Equity in Patient Reported Outcomes | Blog

While significant strides have been made to improve PRO inclusion in clinical trials and routine clinical practice, strategies to include underserved groups are in short supply.

#10

Look Inward to Improve Diversity, Equality & Inclusion in the Biopharmaceutical Industry | Perspectives

In a time of deep unrest amid significant social and health inequity, life sciences leaders are confronting calls to address systemic racism and inequities in the biopharmaceutical industry.

#11

Amplifying the Voice of a Community through Song | Blog

There’s incredible power of a program that is shaped–from beginning to end–by voices from within a community.

#12

Social Media + Measurable KPI's | Blog

The main screen at the Lions Health Festival at Cannes showed the newest player in the fast-changing world of social media healthcare communications: social media interactions with measurable KPIs.

#13

Activating DE&I in Healthcare | Blog

Syneos Health Communications is raising the bar internally and for clients by convening the Syneos DEI Advisory Council to provide insights, consultation, and expertise.

#14

Outsiders are Getting into the Game | Blog

Last month the Cleveland Clinic held their annual Medical Innovation Summit.

#15

Is Pharma More Innovative Than Ever? | Blog

Last year it looked like pharmaceutical companies might be left behind in the wave of innovation changing healthcare experience.

#16

Post-Traumatic Growth and How We Move Forward From COVID-19 | Blog

COVID-19 has changed the way we think, live, and work.

#17

Endorsing Digital Inclusion in Patient Reported Outcomes | Blog

Learn more about the digital divide, how it relates to patient-reported outcomes, and how we're addressing these issues at Syneos Health Communications.

#18

Patient USA: The FDA on Minorities and Clinical Trials | Blog

Martin Mendoza, Director of Extramural Research, Office of Minority Health at the FDA, shared a perspective on inclusion and diversity in clinical trials.

#19

Why Brand and Innovation Need More Integration to Realize Commercial Value | Blog

Looking at what the conventionally siloed functions of Brand and Innovation stand to gain from collaborating.

#20

Integrating Pharmaceutical Brand + Payer to Maximize Brand Value | Blog

As recently as five short years ago, a pharmaceutical manufacturer could develop a good product, do everything right as it pertained to the needs of both patients and healthcare professionals, and launch it successfully into the world without major worry about the product be

#21

Fighting for Creativity: 4th Time's the Charm | Blog

Live From Lions Health: What better way to kickoff a conference on creativity in healthcare than hearing from someone who faced big, difficult challenges and used resilience and imagination to overcome them?

#22

Doximity wins doctor social wars | Blog

Every year around this time Manhattan Research publishes a list of the top apps preferred by doctors.

#23

When It Comes to Artificial Intelligence in Healthcare, Patients Fear the Replacement of Doctors, Yet Are Open to AI Nurse Support | In The Media

New Data from Global Survey Reveals Expectations and Concerns of Patients and Caregivers Confronting a Future with Artificial Intelligence

#24

Mindset Engine POV: Time is the Enemy of Breast Cancer Care | Blog

Tap into insights from the Mindset Engine, a proprietary intelligence platform powered by Syneos Health, to understand how time (or lack thereof) interferes with HPC's abilities to provide breast cancer care, and how healthcare communicators can help.

#25

Your 2023 Business Plan: Differentiate Your Business by Prioritizing an Inclusive Workplace Culture | Blog

Syneos DEI Advisory Council members share strategies for promoting inclusive workforce behaviors that will position business leaders to sustain their organizations through emerging industry challenges, trends, and regulations.

#26

What the CMS National Coverage Decision Means for the Life Science Industry   | Blog

What the CMS National Coverage Decision Means for the Life Science Industry  

#27

The Week That Was: Green, Red, White and Blue | Blog

This week's edition of The Week That Was details how health and medical groups are taking action to address the “greatest public health challenge of the 21st century” and what you need to know from a busy week in healthcare policy.

#28

What happened...to Martin Shkreli | Blog

We hope you had a restful weekend, because you’re in for a helping heap of The Week That Was.